{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:51:03Z","timestamp":1791582663113,"version":"4.3.4"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00210-026-05648-4","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T03:02:17Z","timestamp":1782788537000},"page":"19877-19891","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["From molecular mechanisms to digital surveillance: the 2010\u20132025 evolution of benzodiazepine and Z-drug misuse research"],"prefix":"10.1007","volume":"399","author":[{"given":"Jianxi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weitao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinglin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"5648_CR1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.yebeh.2011.11.005","volume":"23","author":"A Albiero","year":"2012","unstructured":"Albiero A, Brigo F, Faccini M et al (2012) Focal nonconvulsive seizures during detoxification for benzodiazepine abuse. Epilepsy Behav 23:168\u2013170. https:\/\/doi.org\/10.1016\/j.yebeh.2011.11.005","journal-title":"Epilepsy Behav"},{"key":"5648_CR2","doi-asserted-by":"publisher","unstructured":"American Geriatrics Society (2023) updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. https:\/\/doi.org\/10.1111\/jgs.18372","DOI":"10.1111\/jgs.18372"},{"key":"5648_CR3","doi-asserted-by":"publisher","first-page":"634","DOI":"10.17344\/acsi.2023.8465","volume":"70","author":"A Antovi\u0107","year":"2023","unstructured":"Antovi\u0107 A, Karad\u017ei\u0107 R, \u017divkovi\u0107 JV, Veselinovi\u0107 AM (2023) Development of QSAR model based on Monte Carlo optimization for predicting GABAA receptor binding of newly emerging benzodiazepines. Acta Chim Slov 70:634\u2013641. https:\/\/doi.org\/10.17344\/acsi.2023.8465","journal-title":"Acta Chim Slov"},{"key":"5648_CR4","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/7854_2009_30","volume":"2","author":"JR Atack","year":"2010","unstructured":"Atack JR (2010) GABAA receptor alpha2\/alpha3 subtype-selective modulators as potential nonsedating anxiolytics. Curr Top Behav Neurosci 2:331\u2013360. https:\/\/doi.org\/10.1007\/7854_2009_30","journal-title":"Curr Top Behav Neurosci"},{"key":"5648_CR5","doi-asserted-by":"publisher","first-page":"686","DOI":"10.2105\/AJPH.2016.303061","volume":"106","author":"MA Bachhuber","year":"2016","unstructured":"Bachhuber MA, Hennessy S, Cunningham CO, Starrels JL (2016) Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996\u20132013. Am J Public Health 106:686\u2013688. https:\/\/doi.org\/10.2105\/AJPH.2016.303061","journal-title":"Am J Public Health"},{"key":"5648_CR6","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/s0014-5793(98)00803-5","volume":"431","author":"JA Benson","year":"1998","unstructured":"Benson JA, L\u00f6w K, Keist R et al (1998) Pharmacology of recombinant gamma-aminobutyric acidA receptors rendered diazepam-insensitive by point-mutated alpha-subunits. FEBS Lett 431:400\u2013404. https:\/\/doi.org\/10.1016\/s0014-5793(98)00803-5","journal-title":"FEBS Lett"},{"key":"5648_CR7","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/jat\/bkt063","volume":"37","author":"E Bertol","year":"2013","unstructured":"Bertol E, Vaiano F, Borsotti M et al (2013) Comparison of immunoassay screening tests and LC-MS-MS for urine detection of benzodiazepines and their metabolites: results of a national proficiency test. J Anal Toxicol 37:659\u2013664. https:\/\/doi.org\/10.1093\/jat\/bkt063","journal-title":"J Anal Toxicol"},{"key":"5648_CR8","doi-asserted-by":"publisher","unstructured":"Bobrova V, Desselle S, Hein\u00e4m\u00e4ki J, Volmer D (2026) A comparative evaluation of two clinical decision support systems for safer prescribing in older adults: an exploratory single-patient case study. Front Pharmacol 17. https:\/\/doi.org\/10.3389\/fphar.2026.1830248","DOI":"10.3389\/fphar.2026.1830248"},{"key":"5648_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ph14080720","volume":"14","author":"V Catalani","year":"2021","unstructured":"Catalani V, Botha M, Corkery JM et al (2021) The psychonauts\u2019 benzodiazepines; quantitative structure-activity relationship (QSAR) analysis and docking prediction of their biological activity. Pharmaceuticals (Basel) 14:720. https:\/\/doi.org\/10.3390\/ph14080720","journal-title":"Pharmaceuticals (Basel)"},{"key":"5648_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ph14080720","volume":"14","author":"V Catalani","year":"2021","unstructured":"Catalani V, Botha M, Corkery JM et al (2021) The psychonauts\u2019 benzodiazepines; quantitative structure-activity relationship (QSAR) analysis and docking prediction of their biological activity. Pharmaceuticals 14:720. https:\/\/doi.org\/10.3390\/ph14080720","journal-title":"Pharmaceuticals"},{"key":"5648_CR11","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/asi.20317","volume":"57","author":"C Chen","year":"2006","unstructured":"Chen C (2006) CiteSpace II: detecting and visualizing emerging trends and transient patterns in scientific literature. J Am Soc Inf Sci 57:359\u2013377. https:\/\/doi.org\/10.1002\/asi.20317","journal-title":"J Am Soc Inf Sci"},{"key":"5648_CR12","doi-asserted-by":"publisher","first-page":"10698","DOI":"10.1039\/D3CP05050E","volume":"26","author":"J Chen","year":"2024","unstructured":"Chen J, Gou Q, Chen X et al (2024) Exploring biased activation characteristics by molecular dynamics simulation and machine learning for the \u03bc-opioid receptor. Phys Chem Chem Phys 26:10698\u201310710. https:\/\/doi.org\/10.1039\/D3CP05050E","journal-title":"Phys Chem Chem Phys"},{"key":"5648_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/biom15030423","volume":"15","author":"J Chung","year":"2025","unstructured":"Chung J, Hahn H, Flores-Espinoza E, Thomsen ARB (2025) Artificial intelligence: a new tool for structure-based G protein-coupled receptor drug discovery. Biomolecules 15:423. https:\/\/doi.org\/10.3390\/biom15030423","journal-title":"Biomolecules"},{"key":"5648_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2023.102771","volume":"84","author":"A Cicho\u0144ska","year":"2024","unstructured":"Cicho\u0144ska A, Ravikumar B, Rahman R (2024) AI for targeted polypharmacology: the next frontier in drug discovery. Curr Opin Struct Biol 84:102771. https:\/\/doi.org\/10.1016\/j.sbi.2023.102771","journal-title":"Curr Opin Struct Biol"},{"key":"5648_CR15","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1038\/s41467-025-56690-4","volume":"16","author":"JL Cummings","year":"2025","unstructured":"Cummings JL, Zhou Y, Van Stone A et al (2025) Drug repurposing for Alzheimer\u2019s disease and other neurodegenerative disorders. Nat Commun 16:1755. https:\/\/doi.org\/10.1038\/s41467-025-56690-4","journal-title":"Nat Commun"},{"key":"5648_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s40801-024-00474-7","volume":"12","author":"RM da Silva","year":"2025","unstructured":"da Silva RM, Lucchetti ALG, Ferreira MEC et al (2025) Association between inappropriate prescribing according to the 2023 beers criteria and different health outcomes: a 1-year longitudinal study in community-dwelling older adults. Drugs Real World Outcomes 12:93\u2013103. https:\/\/doi.org\/10.1007\/s40801-024-00474-7","journal-title":"Drugs Real World Outcomes"},{"key":"5648_CR17","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464","volume":"315","author":"D Dowell","year":"2016","unstructured":"Dowell D, Haegerich TM, Chou R (2016) CDC guideline for prescribing opioids for chronic pain\u2013United States, 2016. JAMA 315:1624\u20131645. https:\/\/doi.org\/10.1001\/jama.2016.1464","journal-title":"JAMA"},{"key":"5648_CR18","doi-asserted-by":"publisher","unstructured":"Edinoff AN, Nix CA, Hollier J et al (2021) Benzodiazepines: uses, dangers, and clinical considerations. Neurol Int 13:594\u2013607. https:\/\/doi.org\/10.3390\/neurolint13040059","DOI":"10.3390\/neurolint13040059"},{"key":"5648_CR19","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/FTD.0000000000001071","volume":"45","author":"S El Balkhi","year":"2023","unstructured":"El Balkhi S, Abbara C (2023) Designer benzodiazepines: effects, toxicity, and interactions. Ther Drug Monit 45:494\u2013507. https:\/\/doi.org\/10.1097\/FTD.0000000000001071","journal-title":"Ther Drug Monit"},{"key":"5648_CR20","doi-asserted-by":"publisher","first-page":"62a","DOI":"10.1016\/j.bpj.2017.11.390","volume":"114","author":"AB Farimani","year":"2018","unstructured":"Farimani AB, Feinberg E, Pande V (2018) Binding pathway of opiates to \u03bc-opioid receptors revealed by machine learning. Biophys J 114:62a\u201363a. https:\/\/doi.org\/10.1016\/j.bpj.2017.11.390","journal-title":"Biophys J"},{"key":"5648_CR21","doi-asserted-by":"publisher","first-page":"56a","DOI":"10.1016\/j.bpj.2017.11.359","volume":"114","author":"EN Feinberg","year":"2018","unstructured":"Feinberg EN, Pande VS, Farimani AB, Hernandez CX (2018) Kinetic machine learning unravels ligand-directed conformational change of \u03bc opioid receptor. Biophys J 114:56a. https:\/\/doi.org\/10.1016\/j.bpj.2017.11.359","journal-title":"Biophys J"},{"key":"5648_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.106921","volume":"160","author":"H Feng","year":"2023","unstructured":"Feng H, Jiang J, Wei G-W (2023) Machine-learning repurposing of DrugBank compounds for opioid use disorder DrugBank. Comput Biol Med 160:106921. https:\/\/doi.org\/10.1016\/j.compbiomed.2023.106921","journal-title":"Comput Biol Med"},{"key":"5648_CR23","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.1093\/ajhp\/zxz222","volume":"76","author":"M Fortenberry","year":"2019","unstructured":"Fortenberry M, Odinet J, Shah P et al (2019) Development of an electronic trigger tool at a children\u2019s hospital within an academic medical center. Am J Health-Syst Pharm 76:S107\u2013S113. https:\/\/doi.org\/10.1093\/ajhp\/zxz222","journal-title":"Am J Health-Syst Pharm"},{"key":"5648_CR24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s00044-010-9306-5","volume":"20","author":"A Gaurav","year":"2011","unstructured":"Gaurav A, Yadav MR, Giridhar R et al (2011) 3D-QSAR studies of 4-quinolone derivatives as high-affinity ligands at the benzodiazepine site of brain GABAA receptors. Med Chem Res 20:192\u2013199. https:\/\/doi.org\/10.1007\/s00044-010-9306-5","journal-title":"Med Chem Res"},{"key":"5648_CR25","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/jat\/bku025","volume":"38","author":"C Giaginis","year":"2014","unstructured":"Giaginis C, Tsantili-Kakoulidou A, Theocharis S (2014) Applying quantitative structure-activity relationship (QSAR) methodology for modeling postmortem redistribution of benzodiazepines and tricyclic antidepressants. J Anal Toxicol 38:242\u2013248. https:\/\/doi.org\/10.1093\/jat\/bku025","journal-title":"J Anal Toxicol"},{"key":"5648_CR26","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1517\/14656566.2012.667074","volume":"13","author":"DJ Greenblatt","year":"2012","unstructured":"Greenblatt DJ, Roth T (2012) Zolpidem for insomnia. Expert Opin Pharmacother 13:879\u2013893. https:\/\/doi.org\/10.1517\/14656566.2012.667074","journal-title":"Expert Opin Pharmacother"},{"key":"5648_CR27","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12967-021-02910-6","volume":"19","author":"D Hartl","year":"2021","unstructured":"Hartl D, de Luca V, Kostikova A et al (2021) Translational precision medicine: an industry perspective. J Transl Med 19:245. https:\/\/doi.org\/10.1186\/s12967-021-02910-6","journal-title":"J Transl Med"},{"key":"5648_CR28","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1146\/annurev-pharmtox-040323-040828","volume":"64","author":"C Hasselgren","year":"2024","unstructured":"Hasselgren C, Oprea TI (2024) Artificial intelligence for drug discovery: are we there yet? Annu Rev Pharmacol Toxicol 64:527\u2013550. https:\/\/doi.org\/10.1146\/annurev-pharmtox-040323-040828","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"5648_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1006689","volume":"15","author":"X Hu","year":"2019","unstructured":"Hu X, Wang Y, Hunkele A et al (2019) Kinetic and thermodynamic insights into sodium ion translocation through the \u03bc-opioid receptor from molecular dynamics and machine learning analysis. PLoS Comput Biol 15:e1006689. https:\/\/doi.org\/10.1371\/journal.pcbi.1006689","journal-title":"PLoS Comput Biol"},{"key":"5648_CR30","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s40268-019-00282-3","volume":"19","author":"B Ji","year":"2019","unstructured":"Ji B, Liu S, Xue Y et al (2019) Prediction of drug-drug interactions between opioids and overdosed benzodiazepines using physiologically based pharmacokinetic (PBPK) modeling and simulation. Drugs R&D 19:297\u2013305. https:\/\/doi.org\/10.1007\/s40268-019-00282-3","journal-title":"Drugs R&D"},{"key":"5648_CR31","doi-asserted-by":"publisher","unstructured":"Landolfi L, Catalanotti B, Janet JP (2025) Finding balance: multi-objective optimization in molecular generative modeling. ChemRxiv 2025. https:\/\/doi.org\/10.26434\/chemrxiv-2025-1h1qd","DOI":"10.26434\/chemrxiv-2025-1h1qd"},{"key":"5648_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2025.101591","volume":"59","author":"KJ Lee","year":"2025","unstructured":"Lee KJ, Wei Y, Leung S-M et al (2025) A decade of benzodiazepine and Z-drug use in Hongkong: a longitudinal study. Lancet Reg Health West Pac 59:101591. https:\/\/doi.org\/10.1016\/j.lanwpc.2025.101591","journal-title":"Lancet Reg Health West Pac"},{"key":"5648_CR33","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMp1715050","volume":"378","author":"A Lembke","year":"2018","unstructured":"Lembke A, Papac J, Humphreys K (2018) Our other prescription drug problem. N Engl J Med 378:693\u2013695. https:\/\/doi.org\/10.1056\/NEJMp1715050","journal-title":"N Engl J Med"},{"key":"5648_CR34","doi-asserted-by":"publisher","first-page":"10111","DOI":"10.1007\/s00210-026-05016-2","volume":"399","author":"S Li","year":"2026","unstructured":"Li S, Miao W, Tao Q et al (2026) Pharmacovigilance study and genetic target prediction analysis of FDA adverse event reporting system for anticancer drug-associated interstitial lung disease. Naunyn-Schmiedebergs Arch Pharmacol 399:10111\u201310128. https:\/\/doi.org\/10.1007\/s00210-026-05016-2","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"5648_CR35","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.2146\/ajhp150481","volume":"73","author":"D Lim","year":"2016","unstructured":"Lim D, Melucci J, Rizer MK et al (2016) Detection of adverse drug events using an electronic trigger tool. Am J Health Syst Pharm 73:S112\u2013S120. https:\/\/doi.org\/10.2146\/ajhp150481","journal-title":"Am J Health Syst Pharm"},{"key":"5648_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-042299","volume":"11","author":"EY Liu","year":"2021","unstructured":"Liu EY, Tamblyn R, Filion KB, Buckeridge DL (2021) Concurrent prescriptions for opioids and benzodiazepines and risk of opioid overdose: protocol for a retrospective cohort study using linked administrative data. BMJ Open 11:e042299. https:\/\/doi.org\/10.1136\/bmjopen-2020-042299","journal-title":"BMJ Open"},{"key":"5648_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/ebm.2025.10359","volume":"250","author":"J Liu","year":"2025","unstructured":"Liu J, Li J, Li Z et al (2025) Developing predictive models for \u00b5 opioid receptor binding using machine learning and deep learning techniques. Exp Biol Med (Maywood) 250:10359. https:\/\/doi.org\/10.3389\/ebm.2025.10359","journal-title":"Exp Biol Med (Maywood)"},{"key":"5648_CR38","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1080\/17460441.2026.2661209","volume":"21","author":"B Liu","year":"2026","unstructured":"Liu B, Liu J, Guo W et al (2026) Leveraging machine learning for selective cannabinoid ligand discovery: methods, challenges, and opportunities. Expert Opin Drug Discov 21:517\u2013532. https:\/\/doi.org\/10.1080\/17460441.2026.2661209","journal-title":"Expert Opin Drug Discov"},{"key":"5648_CR39","doi-asserted-by":"publisher","first-page":"e190968","DOI":"10.1001\/jamanetworkopen.2019.0968","volume":"2","author":"W-H Lo-Ciganic","year":"2019","unstructured":"Lo-Ciganic W-H, Huang JL, Zhang HH et al (2019) Evaluation of machine-learning algorithms for predicting opioid overdose risk among Medicare beneficiaries with opioid prescriptions. JAMA Netw Open 2:e190968. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.0968","journal-title":"JAMA Netw Open"},{"key":"5648_CR40","doi-asserted-by":"publisher","first-page":"e363","DOI":"10.4088\/JCP.16m10713","volume":"78","author":"DT Maust","year":"2017","unstructured":"Maust DT, Blow FC, Wiechers IR et al (2017) National trends in antidepressant, benzodiazepine, and other sedative-hypnotic treatment of older adults in psychiatric and primary care. J Clin Psychiatry 78:e363\u2013e371. https:\/\/doi.org\/10.4088\/JCP.16m10713","journal-title":"J Clin Psychiatry"},{"key":"5648_CR41","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40360-023-00674-x","volume":"24","author":"DT Maust","year":"2023","unstructured":"Maust DT, Bohnert ASB, Strominger J, Goldstick JE (2023) Prescription characteristics associated with drug overdose risk among adults prescribed benzodiazepines: a cohort study. BMC Pharmacol Toxicol 24:34. https:\/\/doi.org\/10.1186\/s40360-023-00674-x","journal-title":"BMC Pharmacol Toxicol"},{"key":"5648_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.vascn.2019.106649","volume":"101","author":"A Mina","year":"2020","unstructured":"Mina A (2020) Comparison of several immunoassays used in drugs of abuse screening: assessment against gold standard methods and calculation of measurement uncertainty. J Pharmacol Toxicol Methods 101:106649. https:\/\/doi.org\/10.1016\/j.vascn.2019.106649","journal-title":"J Pharmacol Toxicol Methods"},{"key":"5648_CR43","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s00044-008-9111-6","volume":"18","author":"MM Neaz","year":"2009","unstructured":"Neaz MM, Muddassar M, Pasha FA, Cho SJ (2009) 2D-QSAR of non-benzodiazepines to benzodiazepines receptor (BZR). Med Chem Res 18:98\u2013111. https:\/\/doi.org\/10.1007\/s00044-008-9111-6","journal-title":"Med Chem Res"},{"key":"5648_CR44","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1021\/acschemneuro.4c00212","volume":"15","author":"M Oh","year":"2024","unstructured":"Oh M, Shen M, Liu R et al (2024) Machine learned classification of ligand intrinsicactivities at human \u03bc-opioid receptor. ACS Chem Neurosci 15:2842\u20132852. https:\/\/doi.org\/10.1021\/acschemneuro.4c00212","journal-title":"ACS Chem Neurosci"},{"key":"5648_CR45","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","volume":"72","author":"M Olfson","year":"2015","unstructured":"Olfson M, King M, Schoenbaum M (2015) Benzodiazepine use in the United States. JAMA Psychiat 72:136\u2013142. https:\/\/doi.org\/10.1001\/jamapsychiatry.2014.1763","journal-title":"JAMA Psychiat"},{"key":"5648_CR46","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jchromb.2016.08.047","volume":"1035","author":"M Pettersson Bergstrand","year":"2016","unstructured":"Pettersson Bergstrand M, Helander A, Beck O (2016) Development and application of a multi-component LC-MS\/MS method for determination of designer benzodiazepines in urine. J Chromatogr B Analyt Technol Biomed Life Sci 1035:104\u2013110. https:\/\/doi.org\/10.1016\/j.jchromb.2016.08.047","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"5648_CR47","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/dta.2003","volume":"9","author":"M Pettersson Bergstrand","year":"2017","unstructured":"Pettersson Bergstrand M, Helander A, Hansson T, Beck O (2017) Detectability of designer benzodiazepines in CEDIA, EMIT II plus, HEIA, and KIMS II immunochemical screening assays. Drug Test Anal 9:640\u2013645. https:\/\/doi.org\/10.1002\/dta.2003","journal-title":"Drug Test Anal"},{"key":"5648_CR48","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1176\/appi.ajp.20230075","volume":"181","author":"TW Rosenqvist","year":"2024","unstructured":"Rosenqvist TW, Wium-Andersen MK, Wium-Andersen IK et al (2024) Long-term use of benzodiazepines and benzodiazepine-related drugs: a register-based Danish cohort study on determinants and risk of dose escalation. Am J Psychiatry 181:246\u2013254. https:\/\/doi.org\/10.1176\/appi.ajp.20230075","journal-title":"Am J Psychiatry"},{"key":"5648_CR49","doi-asserted-by":"publisher","unstructured":"Rossi B, Freni F, Vignali C et al (2021) Comparison of two immunoassay screening methods and a LC-MS\/MS in detecting traditional and designer benzodiazepines in urine. Molecules 27:. https:\/\/doi.org\/10.3390\/molecules27010112","DOI":"10.3390\/molecules27010112"},{"key":"5648_CR50","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1017\/s1092852900009895","volume":"10","author":"JK Rowlett","year":"2005","unstructured":"Rowlett JK, Cook JM, Duke AN, Platt DM (2005) Selective antagonism of GABAA receptor subtypes: an in vivo approach to exploring the therapeutic and side effects of benzodiazepine-type drugs. CNS Spectr 10:40\u201348. https:\/\/doi.org\/10.1017\/s1092852900009895","journal-title":"CNS Spectr"},{"key":"5648_CR51","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/qsar.200630072","volume":"26","author":"K Roy","year":"2007","unstructured":"Roy K, Toropov A, Raska I Jr (2007) QSAR modeling of peripheral versus central benzodiazepine receptor binding affinity of 2-phenylimidazo[1,2-a]pyridineacetamides using optimal descriptors calculated with SMILES. QSAR Comb Sci 26:460\u2013468. https:\/\/doi.org\/10.1002\/qsar.200630072","journal-title":"QSAR Comb Sci"},{"key":"5648_CR52","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nrd3502","volume":"10","author":"U Rudolph","year":"2011","unstructured":"Rudolph U, Knoflach F (2011) Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes. Nat Rev Drug Discov 10:685\u2013697. https:\/\/doi.org\/10.1038\/nrd3502","journal-title":"Nat Rev Drug Discov"},{"key":"5648_CR53","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/44579","volume":"401","author":"U Rudolph","year":"1999","unstructured":"Rudolph U, Crestani F, Benke D et al (1999) Benzodiazepine actions mediated by specific gamma-aminobutyric acid(a) receptor subtypes. Nature 401:796\u2013800. https:\/\/doi.org\/10.1038\/44579","journal-title":"Nature"},{"key":"5648_CR54","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nrd3295","volume":"9","author":"R Rupprecht","year":"2010","unstructured":"Rupprecht R, Papadopoulos V, Rammes G et al (2010) Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat Rev Drug Discov 9:971\u2013988. https:\/\/doi.org\/10.1038\/nrd3295","journal-title":"Nat Rev Drug Discov"},{"key":"5648_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci8040073","volume":"8","author":"F Schifano","year":"2018","unstructured":"Schifano F, Chiappini S, Corkery JM, Guirguis A (2018) Abuse of prescription drugs in the context of novel psychoactive substances (NPS): a systematic review. Brain Sci 8:73. https:\/\/doi.org\/10.3390\/brainsci8040073","journal-title":"Brain Sci"},{"key":"5648_CR56","doi-asserted-by":"publisher","unstructured":"Shin LM, Liberzon I (2010) The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology 35:169\u2013191. https:\/\/doi.org\/10.1038\/npp.2009.83","DOI":"10.1038\/npp.2009.83"},{"key":"5648_CR57","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1001\/jamainternmed.2025.6084","volume":"186","author":"B Shuey","year":"2026","unstructured":"Shuey B, Anderson TS, Park TW (2026) Implementing benzodiazepine deprescribing in the primary care clinic. JAMA Intern Med 186:120\u2013121. https:\/\/doi.org\/10.1001\/jamainternmed.2025.6084","journal-title":"JAMA Intern Med"},{"key":"5648_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-14-191","volume":"14","author":"C Sirdifield","year":"2013","unstructured":"Sirdifield C, Anthierens S, Creupelandt C et al (2013) General practitioners\u2019 experiences and perceptions of benzodiazepine prescribing: systematic review and meta-synthesis. BMC Fam Pract 14:191. https:\/\/doi.org\/10.1186\/1471-2296-14-191","journal-title":"BMC Fam Pract"},{"key":"5648_CR59","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.neuropharm.2012.03.001","volume":"63","author":"KS Smith","year":"2012","unstructured":"Smith KS, Engin E, Meloni EG, Rudolph U (2012) Benzodiazepine-induced anxiolysis and reduction of conditioned fear are mediated by distinct GABAA receptor subtypes in mice. Neuropharmacology 63:250\u2013258. https:\/\/doi.org\/10.1016\/j.neuropharm.2012.03.001","journal-title":"Neuropharmacology"},{"key":"5648_CR60","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1056\/NEJMra1611832","volume":"376","author":"M Soyka","year":"2017","unstructured":"Soyka M (2017) Treatment of benzodiazepine dependence. N Engl J Med 376:1147\u20131157. https:\/\/doi.org\/10.1056\/NEJMra1611832","journal-title":"N Engl J Med"},{"key":"5648_CR61","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j760","volume":"356","author":"EC Sun","year":"2017","unstructured":"Sun EC, Dixit A, Humphreys K et al (2017) Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis. BMJ 356:j760. https:\/\/doi.org\/10.1136\/bmj.j760","journal-title":"BMJ"},{"key":"5648_CR62","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nature08758","volume":"463","author":"KR Tan","year":"2010","unstructured":"Tan KR, Brown M, Labou\u00e8be G et al (2010) Neural bases for addictive properties of benzodiazepines. Nature 463:769\u2013774. https:\/\/doi.org\/10.1038\/nature08758","journal-title":"Nature"},{"key":"5648_CR63","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.tins.2011.01.004","volume":"34","author":"KR Tan","year":"2011","unstructured":"Tan KR, Rudolph U, L\u00fcscher C (2011) Hooked on benzodiazepines: GABAA receptor subtypes and addiction. Trends Neurosci 34:188\u2013197. https:\/\/doi.org\/10.1016\/j.tins.2011.01.004","journal-title":"Trends Neurosci"},{"key":"5648_CR64","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","volume":"174","author":"C Tannenbaum","year":"2014","unstructured":"Tannenbaum C, Martin P, Tamblyn R et al (2014) Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med 174:890\u2013898. https:\/\/doi.org\/10.1001\/jamainternmed.2014.949","journal-title":"JAMA Intern Med"},{"key":"5648_CR65","doi-asserted-by":"publisher","first-page":"5203","DOI":"10.1016\/j.bmc.2003.08.014","volume":"11","author":"A Thakur","year":"2003","unstructured":"Thakur A, Thakur M, Khadikar P (2003) Topological modeling of benzodiazepine receptor binding. Bioorg Med Chem 11:5203\u20135207. https:\/\/doi.org\/10.1016\/j.bmc.2003.08.014","journal-title":"Bioorg Med Chem"},{"key":"5648_CR66","unstructured":"United Nations Office on Drugs and Crime (2025) World drug report 2025: special points of interest. United Nations, Vienna"},{"key":"5648_CR67","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1021\/ci600216h","volume":"46","author":"M Urbano Cuadrado","year":"2006","unstructured":"Urbano Cuadrado M, Luque Ruiz I, G\u00f3mez-Nieto M\u00c1 (2006) Refinement and use of the approximate similarity in QSAR models for benzodiazepine receptor ligands. J Chem Inf Model 46:2022\u20132029. https:\/\/doi.org\/10.1021\/ci600216h","journal-title":"J Chem Inf Model"},{"key":"5648_CR68","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.bja.2021.10.029","volume":"128","author":"D Vodovar","year":"2022","unstructured":"Vodovar D, Chevillard L, Caill\u00e9 F et al (2022) Mechanisms of respiratory depression induced by the combination of buprenorphine and diazepam in rats. Br J Anaesth 128:584\u2013595. https:\/\/doi.org\/10.1016\/j.bja.2021.10.029","journal-title":"Br J Anaesth"},{"key":"5648_CR69","doi-asserted-by":"publisher","unstructured":"Votaw VR, Geyer R, Rieselbach MM, McHugh RK (2019) The epidemiology of benzodiazepine misuse: a systematic review. Drug Alcohol Depend 200:95\u2013114. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.02.033","DOI":"10.1016\/j.drugalcdep.2019.02.033"},{"key":"5648_CR70","doi-asserted-by":"publisher","unstructured":"Wang S, Song L, Sun Y et al (2025a) An in-depth exploration of the association between olanzapine, quetiapine, and acute pancreatitis based on real-world datasets and network toxicology analysis. Front Pharmacol 16:.https:\/\/doi.org\/10.3389\/fphar.2025.1529416","DOI":"10.3389\/fphar.2025.1529416"},{"key":"5648_CR71","doi-asserted-by":"publisher","unstructured":"Wang W, Liu H, Wen Y et al (2025b) An integrated approach based on FDA adverse event reporting system, network pharmacology, molecular docking, and molecular dynamics simulation analysis to study the cardiac adverse reactions and mechanism of action of osimertinib. Front Pharmacol 16:.https:\/\/doi.org\/10.3389\/fphar.2025.1619517","DOI":"10.3389\/fphar.2025.1619517"},{"key":"5648_CR72","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-026-05108-z","author":"L Wang","year":"2026","unstructured":"Wang L, Xiong R, Liu H et al (2026) Adverse drug events and toxicological mechanisms of esketamine: a study based on US Food and Drug Administration Adverse Event Reporting System and network toxicology analysis. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-026-05108-z","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5648_CR73","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/S0021-9258(18)45961-3","volume":"267","author":"HA Wieland","year":"1992","unstructured":"Wieland HA, L\u00fcddens H, Seeburg PH (1992) A single histidine in GABAA receptors is essential for benzodiazepine agonist binding. J Biol Chem 267:1426\u20131429. https:\/\/doi.org\/10.1016\/S0021-9258(18)45961-3","journal-title":"J Biol Chem"},{"key":"5648_CR74","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.ejmech.2007.09.004","volume":"43","author":"B Xia","year":"2008","unstructured":"Xia B, Ma W, Zheng B et al (2008) Quantitative structure\u2013activity relationship studies of a series of non-benzodiazepine structural ligands binding to benzodiazepine receptor. Eur J Med Chem 43:1489\u20131498. https:\/\/doi.org\/10.1016\/j.ejmech.2007.09.004","journal-title":"Eur J Med Chem"},{"key":"5648_CR75","doi-asserted-by":"publisher","unstructured":"Xie H, Jiang L, Peng J et al (2025) Drug-induced pancreatitis: a real-world analysis of the FDA Adverse Event Reporting System and network pharmacology. Front Pharmacol 16. https:\/\/doi.org\/10.3389\/fphar.2025.1564127","DOI":"10.3389\/fphar.2025.1564127"},{"key":"5648_CR76","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.2147\/JPR.S409380","volume":"16","author":"X Yu","year":"2023","unstructured":"Yu X, Gao Z, Gao M, Qiao M (2023) Bibliometric analysis on GABAA receptors research based on CiteSpace and VOSviewer. J Pain Res 16:2101\u20132114. https:\/\/doi.org\/10.2147\/JPR.S409380","journal-title":"J Pain Res"},{"key":"5648_CR77","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/j.1365-2125.2011.03908.x","volume":"72","author":"G Zamparutti","year":"2011","unstructured":"Zamparutti G, Schifano F, Corkery JM et al (2011) Deaths of opiate\/opioid misusers involving dihydrocodeine, UK, 1997\u20132007. Br J Clin Pharmacol 72:330\u2013337. https:\/\/doi.org\/10.1111\/j.1365-2125.2011.03908.x","journal-title":"Br J Clin Pharmacol"},{"key":"5648_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1042594","volume":"13","author":"M Zhang","year":"2022","unstructured":"Zhang M, Kou L, Qin Y et al (2022) A bibliometric analysis of the recent advances in diazepam from 2012 to 2021. Front Pharmacol 13:1042594. https:\/\/doi.org\/10.3389\/fphar.2022.1042594","journal-title":"Front Pharmacol"},{"key":"5648_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-026-15993-5","author":"S Zhang","year":"2026","unstructured":"Zhang S, Liu J, Feng X et al (2026) Osimertinib-induced interstitial lung disease insights from FAERS signal detection and network toxicology analysis. BMC Cancer. https:\/\/doi.org\/10.1186\/s12885-026-15993-5","journal-title":"BMC Cancer"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05648-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05648-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05648-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:02:13Z","timestamp":1791579733000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05648-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":79,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5648"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05648-4","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"6 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors read and approved the final manuscript.","order":1,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}